In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy - Tout INSP Accéder directement au contenu
Article Dans Une Revue Orphanet Journal of Rare Diseases Année : 2021

In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy

Résumé

Background ABCB11 variations are responsible for a spectrum of rare liver diseases, including progressive familial intrahepatic cholestasis type 2 (PFIC2) and intrahepatic cholestasis of pregnancy (ICP). Current medical treatment of these conditions mostly relies on ursodeoxycholic acid with limited efficacy. We report on the in vitro study of the p.A257V missense variant of ABCB11 identified in a PFIC2 patient and in her mother who experienced ICP. Results The Ala257 residue is located outside the ATP-binding site of ABCB11. We show that the p.A257V variant of ABCB11 is correctly expressed at the canalicular membrane of HepG2 cells but that its function significantly decreased when studied in MDCK cells. This functional defect can be fully rescued by Ivacaftor. Conclusion Ivacaftor could be considered as a new pharmacological tool able to respond to an unmet medical need for patients with ICP and PFIC2 due to ABCB11 variations affecting ABCB11 function, even when the residue involved is not located in an ATP-binding site of ABCB11.
Fichier principal
Vignette du fichier
s13023-021-02125-4.pdf (1.25 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03449278 , version 1 (25-11-2021)

Identifiants

Citer

Elodie Mareux, Martine Lapalus, Amel Ben-Saad, Isabelle Callebaut, Thomas Falguières, et al.. In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy. Orphanet Journal of Rare Diseases, 2021, 16 (1), ⟨10.1186/s13023-021-02125-4⟩. ⟨hal-03449278⟩
30 Consultations
28 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More